Vendor, San Rafael, CA
Biomarin Pharmaceutical Inc.
UEI HDEGEX3YK7H1, CAGE 4C7J0
3 awards and -$24,698 obligated between February 13, 2024 and September 1, 2026, 100% under full and open competition, against 500.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | -$24,698 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
| BPA Call | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79722A0004September 5, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | This Modification Is Issued to Exercise Option Year 3 on BPA 36E79722A0004.NAICS 325412, PSC 6505 | $0 |
| 36F79721D0170May 14, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | AddNAICS 325412, PSC 6505 | $0 |
| 36C26322N0466BPA Call, February 13, 2024, Full and Open Competition | Network Contract Office 23Department of Veterans Affairs | Pegvaliase-Pqpz (Palynziq)NAICS 325412, PSC 6505 | -$24,698 |
- Places of performance
- California
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 15 across 3 awards